Brought to you by 
Smith & Nephew acquires Nucryst for $28mm
29 Jan 2010
Executive Summary
Smith & Nephew Advanced Wound Management has closed its acquisition of Nucryst Pharmaceuticals, a public company with wound care products and pharmaceuticals based on a nanocrystalline silver technology. S&N paid $21mm in cash plus other working capital adjustments of $7mm.
Deal Industry
- Biotechnology
- Medical Devices
- Pharmaceuticals
-
Medical Devices
- Biomaterials
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com